Jiangsu Hengrui Pharmaceuticals Co.,Ltd

600276.SS·Shanghai·Healthcare
Compare
46.08−0.55 (−1.18%)today
At close: Oct 19, 3:00 PM CST · May be delayed up to 15 min · CNY

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close46.63
Open45.93
Day range45.7146.70
52-week range41.8967.85
Off day high−1.33%
Off 52-week high−32.09%
Volume36.86M
Avg. volume (3M)74.18M
Market cap305.84B
EPS (TTM)1.16
Forward P/E29.93
P/E ratio (TTM)39.72
Dividend yield0.38% (0.2000)
Beta (5Y)0.04
Shares outstanding6.38B
Short interest—
Earnings dateAug 20, 2025
Analyst target70.92
Profit margin24.93%

Against its peers

Compare in full ›
600276.SS ZYDUSLIFE.BO UPC SUNPHARMA.NS TAK 068760.KQ
Market cap 305.84B 1.12T 19.75M 4.19T 62.84B 1.77T
P/E (TTM) 39.7 25.0 — 34.7 — —
Forward P/E 29.9 22.7 — 27.0 37.1 —
Price/book 4.9 4.2 0.0 5.0 1.3 —
Dividend yield 0.38% 0.09% — 0.91% 3.13% 0.51%
1-year change −28.40% +12.19% −16.91% +4.16% +39.70% −30.27%
Today −1.18% −0.24% −5.30% −0.71% +1.13% +2.83%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

MarketScreener·Positive

Jiangsu Hengrui Pharmaceuticals Co.,Ltd : Insider Transactions

Follow insider transactions on Jiangsu Hengrui Pharmaceuticals Co.,Ltd in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Jiangsu Hengrui Pharmaceuticals Co.,Ltd Latest…

From articles in the 4Search news index.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.